← Leaderboards
Antoinette M Moran
University Of Minnesota
$24,819,193
Attributed
$32,406,081
Total exposure
53
Grants
40
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,406,081 · 53
By mechanism
R24$10,115,851 · 1
R01$9,412,803 · 3
U01$8,817,034 · 2
T32$3,266,522 · 1
M01$793,871 · 46
Top collaborators
- John F Engelhardt8 shared
- Deborah J. Nelson8 shared
- Andrew W. Norris8 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Dickson Ally Mkoka$2,627,641
- Kristen Patricia Mark$1,522,697
- Maya Luetke$257,634
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinClinical ResearchResourcesResearch PersonnelGrantDiabetes MellitusSourceFundingInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthCystic FibrosisInsulin-Dependent Diabetes MellitusChildhoodHyperglycemiaAdultProtocols DocumentationMinnesotaUniversitiesGlucose TolerancePreventClinical TrialsLungPilot Projects
Grant awards (109)
Diabetes in African Youth: Improving Glucose Time-In-Range$318,233
R01 · FY2025 · DK · contact PI
Diabetes in African Youth: Improving Glucose Time-In-Range$251,721
R01 · FY2025 · DK · contact PI
Diabetes in African Youth: Improving Glucose Time-In-Range$545,309
R01 · FY2024 · DK · contact PI
Diabetes in African Youth: Improving Glucose Time-In-Range$569,125
R01 · FY2023 · DK · contact PI
Diabetes in African Youth: Improving Glucose Time-In-Range$596,683
R01 · FY2022 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$172,227
T32 · FY2022 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$139,990
T32 · FY2021 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$103,943
T32 · FY2020 · DK · contact PI
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients$685,689
R01 · FY2019 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,511,641
R24 · FY2018 · DK
Type 1 Diabetes-A Proposal for Prevention & Intervention$793,334
U01 · FY2018 · DK · contact PI
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients$691,767
R01 · FY2018 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$246,264
T32 · FY2018 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,511,641
R24 · FY2017 · DK
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients$692,030
R01 · FY2017 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$581,567
U01 · FY2017 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$200,179
T32 · FY2017 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,511,641
R24 · FY2016 · DK
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients$692,030
R01 · FY2016 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$581,567
U01 · FY2016 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$187,274
T32 · FY2016 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,497,916
R24 · FY2015 · DK
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients$717,323
R01 · FY2015 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$581,566
U01 · FY2015 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$225,201
T32 · FY2015 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$13,590
R24 · FY2015 · DK
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,523,416
R24 · FY2014 · DK
Type 1 Diabetes-A Proposal for Prevention & Intervention$753,507
U01 · FY2014 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$237,974
T32 · FY2014 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$60,774
U01 · FY2014 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,231,688
R24 · FY2013 · DK
Type 1 Diabetes-A Proposal for Prevention & Intervention$705,106
U01 · FY2013 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$209,118
T32 · FY2013 · DK · contact PI
Early Pathogenesis of Cystic Fibrosis Related Diabetes$1,314,318
R24 · FY2012 · DK
Type 1 Diabetes-A Proposal for Prevention & Intervention$570,164
U01 · FY2012 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$200,358
T32 · FY2012 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$817,421
U01 · FY2011 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$199,204
T32 · FY2011 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$891,359
U01 · FY2010 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$197,999
T32 · FY2010 · DK · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$773,947
U01 · FY2009 · DK · contact PI
Pre-faculty Research Training in Pediatric Endocrinology$196,495
T32 · FY2009 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$41,348
M01 · FY2009 · RR · contact PI
EFFECTS OF CTLA-4IG (ABATACEPT) ON THE PROGRESSION OF TYPE 1 DIABETES IN NEW ONS$31,834
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: TYPE 1 DIABETES TRIALNET - MMF/DZB$17,929
M01 · FY2009 · RR · contact PI
NUTRITIONAL INTERVENTION TO PREVENT (NIP) TYPE 1 DIABETES PILOT STUDY$13,538
M01 · FY2009 · RR · contact PI
THE AUTOIMMUNE BASIS OF CFRD$10,977
M01 · FY2009 · RR · contact PI
EFFECT OF ANTITHYMOCYTE GLOBULIN ON PRESERVING BETA-CELL FUNCTION IN NEW ONSET T$7,684
M01 · FY2009 · RR · contact PI
THE GENETIC BASIS OF CFRD$6,221
M01 · FY2009 · RR · contact PI
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABETES$5,854
M01 · FY2009 · RR · contact PI
METABOLIC OUTCOME AFTER ISLET TRANSPLANTATION IN T1DM: A PILOT STUDY$5,489
M01 · FY2009 · RR · contact PI
DIABETES THERAPY TO IMPROVE MUSCLE MASS IN CF$366
M01 · FY2009 · RR · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$193,751
T32 · FY2008 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$37,545
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: TYPE 1 DIABETES TRIALNET - MMF/DZB$36,662
M01 · FY2008 · RR · contact PI
DIABETES THERAPY TO IMPROVE MUSCLE MASS IN CF$10,160
M01 · FY2008 · RR · contact PI
NUTRITIONAL INTERVENTION TO PREVENT (NIP) TYPE 1 DIABETES PILOT STUDY$9,276
M01 · FY2008 · RR · contact PI
METABOLIC OUTCOME AFTER ISLET TRANSPLANTATION IN T1DM: A PILOT STUDY$5,301
M01 · FY2008 · RR · contact PI
THE TYPE 1 DIABETES GENETICS CONSORTIUM$4,859
M01 · FY2008 · RR · contact PI
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABETES$2,209
M01 · FY2008 · RR · contact PI
INTENSIVE INSULIN THERAPY IN THE HOSPITALIZED CF PATIENT: A PILOT STUDY$1,325
M01 · FY2008 · RR · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$1,018,460
U01 · FY2007 · DK · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$186,873
T32 · FY2007 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$77,057
M01 · FY2007 · RR · contact PI
TYPE 1 DIABETES TRIALNET - MMF/DZB$56,483
M01 · FY2007 · RR · contact PI
DIABETES THERAPY TO IMPROVE MUSCLE MASS IN CF$14,962
M01 · FY2007 · RR · contact PI
THE TYPE 1 DIABETES GENETICS CONSORTIUM$10,473
M01 · FY2007 · RR · contact PI
INTENSIVE INSULIN THERAPY IN THE HOSPITALIZED CF PATIENT: A PILOT STUDY$3,367
M01 · FY2007 · RR · contact PI
METABOLIC OUTCOME AFTER ISLET TRANSPLANTATION IN T1DM: A PILOT STUDY$3,367
M01 · FY2007 · RR · contact PI
NUTRITIONAL INTERVENTION TO PREVENT (NIP) TYPE 1 DIABETES PILOT STUDY$1,496
M01 · FY2007 · RR · contact PI
A COMPARATIVE STUDY BETWEEN 4 T-CELL ASSAYS IN RECENT ONSENT TYPE 1S AND CONTROL$749
M01 · FY2007 · RR · contact PI
Pre-Faculty Research Training in Pediatric Endocrinology$180,638
T32 · FY2006 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$100,789
M01 · FY2006 · RR · contact PI
THE TYPE 1 DIABETES GENETICS CONSORTIUM$24,031
M01 · FY2006 · RR · contact PI
TYPE 1 DIABETES TRIALNET - MMF/DZB$22,238
M01 · FY2006 · RR · contact PI
IMPROVING METABOLIC ASSESSMENTS IN T1DM TRIALS: COMPARING MMTT & IV GLUCAGON STI$20,086
M01 · FY2006 · RR · contact PI
COMPARISON OF INSULIN GLARGINE VS STANDARD INSULIN THERAPY IN CFRD W/FH$12,554
M01 · FY2006 · RR · contact PI
DIABETES THERAPY TO IMPROVE MUSCLE MASS IN CF$8,608
M01 · FY2006 · RR · contact PI
A COMPARATIVE STUDY BETWEEN 4 T-CELL ASSAYS IN RECENT ONSENT TYPE 1S AND CONTROL$7,891
M01 · FY2006 · RR · contact PI
METABOLIC OUTCOME AFTER ISLET TRANSPLANTATION IN T1DM: A PILOT STUDY$3,946
M01 · FY2006 · RR · contact PI
MICROVASCULAR COMPLICATIONS OF CFRD$718
M01 · FY2006 · RR · contact PI
Type 1 Diabetes-A Proposal for Prevention & Intervention$1
U01 · FY2006 · DK · contact PI
Diabetes Therapy to Improve BMI and Lung Function in CF$651,916
R01 · FY2005 · DK
Type 1 Diabetes-A Proposal for Prevention &Intervention$391,892
U01 · FY2005 · DK
Pre-Faculty Research Training in Pediatric Endocrinology$126,722
T32 · FY2005 · DK
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$72,135
M01 · FY2005 · RR
COMPARISON OF INSULIN GLARGINE VS STANDARD INSULIN THERAPY IN CFRD W/FH$30,794
M01 · FY2005 · RR
METABOLIC OUTCOME AFTER ISLET TRANSPLANTATION IN T1DM: A PILOT STUDY$24,889
M01 · FY2005 · RR
THE TYPE 1 DIABETES GENETICS CONSORTIUM$8,015
M01 · FY2005 · RR
TYPE 1 DIABETES TRIALNET - MMF/DZB$4,641
M01 · FY2005 · RR
DIABETES THERAPY TO IMPROVE MUSCLE MASS IN CF$3,797
M01 · FY2005 · RR
MICROVASCULAR COMPLICATIONS OF CFRD$3,375
M01 · FY2005 · RR
Diabetes Therapy to Improve BMI and Lung Function in CF$750,142
R01 · FY2004 · DK
Type 1 Diabetes-A Proposal for Prevention &Intervention$296,369
U01 · FY2004 · DK
Pre-Faculty Research Training in Pediatric Endocrinology$62,312
T32 · FY2004 · DK
Microvascular Complications of CFRD$14,047
M01 · FY2004 · RR
Comparison of Insulin Glargine vs. Standard Insulin Therapy in CFRD w/FH$8,872
M01 · FY2004 · RR
Diabetes Therapy to Improve Muscle Mass in CF$5,914
M01 · FY2004 · RR
Diabetes Therapy to Improve BMI and Lung Function in CF$733,933
R01 · FY2003 · DK
Diabetes Therapy to Improve BMI and Lung Function in CF$714,733
R01 · FY2002 · DK
INSULIN THERAPY TO AMELIORATE PROTEIN CATABOLISM IN NON-DIABETIC CF PATIENTS$0
M01 · FY2002 · RR
INSULIN THERAPY TO AMELIORATE PROTEIN CATABOLISM IN NON-DIABETIC CF PATIENTS$0
M01 · FY2002 · RR
SUBSTRATE UTILIZATION IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
SUBSTRATE UTILIZATION IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
Diabetes Therapy to Improve BMI and Lung Function in CF$802,169
R01 · FY2001 · DK
SUBSTRATE UTILIZATION IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
INSULIN THERAPY TO AMELIORATE PROTEIN CATABOLISM IN NON-DIABETIC CF PATIENTS$0
M01 · FY2001 · RR
SUBSTRATE UTILIZATION IN CYSTIC FIBROSIS$0
M01 · FY2000 · RR
INSULIN THERAPY TO AMELIORATE PROTEIN CATABOLISM IN NON-DIABETIC CF PATIENTS$0
M01 · FY2000 · RR